Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN

Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
Drug Metabolism and Disposition July 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664
Yong Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideaki Okochi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barnaby C. H. May
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Legname
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stanley B. Prusiner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leslie Z. Benet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Joseph Guglielmo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emil T. Lin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 34 no. 7 1136-1144
DOI 
https://doi.org/10.1124/dmd.105.008664
PubMed 
16581945

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received November 28, 2005
  • Accepted March 27, 2006
  • Published online June 21, 2006.

Article Versions

  • Earlier version (March 31, 2006 - 09:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yong Huang,
  2. Hideaki Okochi,
  3. Barnaby C. H. May,
  4. Giuseppe Legname,
  5. Stanley B. Prusiner,
  6. Leslie Z. Benet,
  7. B. Joseph Guglielmo and
  8. Emil T. Lin
  1. Department of Biopharmaceutical Sciences (Y.H., H.O., L.Z.B., E.T.L.), Institute for Neurodegenerative Diseases and Department of Neurology (B.C.H.M., G.L., S.B.P.), Department of Biochemistry and Biophysics (S.B.P), and Department of Clinical Pharmacy (B.J.G.), University of California, San Francisco, California
  1. Address correspondence to:
    Dr. Emil T. Lin, Department of Biopharmaceutical Sciences, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0446. E-mail: etlin{at}itsa.ucsf.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20171208
Sep 201722716
Oct 201722315
Nov 201724219
Dec 20170392
Jan 201811511
Feb 20180194
Mar 20181186
Apr 201802210
May 201801617
Jun 20180194
Jul 20181113
Aug 20180138
Sep 20180135
Oct 20180159
Nov 201804515
Dec 2018271618
Jan 20193624
Feb 20192546
Mar 20191516
Apr 20192153
May 20191205
Jun 2019623
Jul 201910111
Aug 20191003
Oct 20191335
Nov 20193500
Dec 20192015
Jan 20201736
Feb 20203900
Mar 20202411
May 20204532
Jun 2020900
Jul 2020700
Aug 2020514
Sep 20201901
Oct 20202213
Nov 2020955
Dec 20202010
Jan 20211226
Feb 20211916
Mar 20212711
Apr 20215641
May 20213232
Jun 20213425
Jul 20212613
Aug 20211722
Sep 20211610
Oct 20211721
Nov 20212561
Dec 20211912
Jan 20223323
Feb 20222221
Mar 20221211
Apr 2022822
May 20223030
Jun 20222010
Jul 20221427
Aug 20221423
Sep 202210311
Oct 202216912
Nov 20223818
Dec 20221626
Jan 20233225

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 34 (7)
Drug Metabolism and Disposition
Vol. 34, Issue 7
1 Jul 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN

Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
Drug Metabolism and Disposition July 1, 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

QUINACRINE IS MAINLY METABOLIZED TO MONO-DESETHYL QUINACRINE BY CYP3A4/5 AND ITS BRAIN ACCUMULATION IS LIMITED BY P-GLYCOPROTEIN

Yong Huang, Hideaki Okochi, Barnaby C. H. May, Giuseppe Legname, Stanley B. Prusiner, Leslie Z. Benet, B. Joseph Guglielmo and Emil T. Lin
Drug Metabolism and Disposition July 1, 2006, 34 (7) 1136-1144; DOI: https://doi.org/10.1124/dmd.105.008664
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics